KORU Medical Systems (KRMD)

• Market cap: $151M
• 1 day: 5.79%
• 5 days: 3.46%
• 1 month: -29.25%
• 3 months: -25.23%
• 6 months: 30.56%
• Year to date: -15.42%
• 1 year: 56.67%
• 5 years: -47.28%
• 10 years: -17.13%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Employees: 82

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

90% more capital invested

Capital invested by funds: $34.9M [Q3] → $66.1M (+$31.3M) [Q4]

19% more funds holding

Funds holding: 54 [Q3] → 64 (+10) [Q4]

9.65% more ownership

Funds ownership: 27.86% [Q3] → 37.5% (+9.65%) [Q4]

6% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 16

73% less call options, than puts

Call options by funds: $12K | Put options by funds: $45K

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $4.50 37% upside
• Avg. target: $5.17 57% upside
• High target: $6 82% upside

3 analyst ratings

• positive: 2 67%
• neutral: 1 33%
• negative: 0 0%

Piper Sandler Jason Bednar 33% 1-year accuracy 12 / 36 met price target	37% upside $4.50	Neutral Downgraded	14 Feb 2025
Craig-Hallum Chase Knickerbocker 41% 1-year accuracy 11 / 27 met price target	82% upside $6	Buy Maintained	17 Jan 2025
Lake Street Frank Takkinen 45% 1-year accuracy 9 / 20 met price target	52% upside $5	Buy Maintained	14 Jan 2025